Growth Signaling Autonomy in Circulating Tumor Cells Aids Metastatic Seeding
Preprint
Abstract
Self-sufficiency (autonomy) in growth signaling, the earliest recognized hallmark of cancer, is fuelled by the tumor cell’s ability to ‘secrete-and-sense’ growth factors; this translates into cell survival and proliferation that is self-sustained by auto-/paracrine secretion. Using breast cancer cells that are either endowed or impaired in growth signaling autonomy, here we reveal how autonomy impacts cancer progression. Autonomy is associated with enhanced molecular programs for stemness, immune evasiveness, proliferation, and epithelial-mesenchymal plasticity (EMP). Autonomy is both necessary and sufficient for anchorage-independent growth factor-restricted proliferation and resistance to anti-cancer drugs and is required for metastatic progression. Transcriptomic and proteomic studies show that autonomy is associated with self-sustained EGFR/ErbB signaling. A gene expression signature is derived (a.k.a., autonomy signature) which revealed that autonomy is induced in circulating tumor cells (CTCs) and particularly CTC clusters, the latter of which carry higher metastatic potential. Autonomy in CTCs tracks therapeutic response and prognosticates outcome. Autonomy is preserved during reversible (but not stable) epithelial-mesenchymal transition (EMT). These data support a role for growth signaling autonomy in multiple processes essential for the blood-borne dissemination of human breast cancer. In Brief In this work, Sinha et al., reveal a special feature in a subset of circulating tumor cells, i.e., growth signaling autonomy, which makes them better ‘seeds’ for initiating metastases in breast cancer. HIGHLIGHTS Autonomy is associated with stemness, immune evasiveness, EM-plasticity, and metastatic potential Autonomous tumor cells mount a self-sufficient EGFR/ErbB signaling program Autonomy is induced during reversible (not stable) EMT and requires EGFR/ERBB signaling Gene signature for autonomy in CTCs tracks therapeutic response and prognosticates outcomeKeywords
All Related Versions
- Published version: PNAS Nexus, 3 (2), pgae014.
This publication has 83 references indexed in Scilit:
- EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras PathwayPLOS ONE, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Three differentiation states risk-stratify bladder cancer into distinct subtypesProceedings of the National Academy of Sciences, 2012
- Single-cell dissection of transcriptional heterogeneity in human colon tumorsNature Biotechnology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patientsBreast Cancer Research, 2008
- Extracting binary signals from microarray time-course dataNucleic Acids Research, 2007
- NCBI GEO: mining tens of millions of expression profiles--database and tools updateNucleic Acids Research, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002